LOS ANGELES, CA / ACCESSWIRE / April 25, 2024 / The Schall Law Firm, a

national shareholder rights litigation firm, announces the filing of a class

action lawsuit against Ventyx Biosciences, Inc. ("Ventyx" or "the Company")

(NASDAQ:VTYX) for violations of the federal securities laws.

Investors who purchased the Company's securities pursuant and/or traceable to

the Company's Offering Documents in connection with its initial public

offering ("IPO") conducted on or about October 21, 2021 and/or between October

21, 2021 through November 6, 2023, inclusive (the "Class Period"), are

encouraged to contact the firm before April 30, 2024.

If you are a shareholder who suffered a loss, click here to participate.

(https://pr.report/6TzVK5v-)

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049

Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to

discuss your rights free of charge. You can also reach us through the firm's

website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class, in this case, has not yet been certified, and until certification

occurs, you are not represented by an attorney. If you choose to take no

action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements

to the market. The lead clinical product candidate developed by Ventyx,

VTX958, was less effective in the treatment of psoriasis than it portrayed to

investors. The Company overstated the commercial prospects of VTX958. The

Company misrepresented its ability to develop and commercialize drug

candidates. Based on these facts, the Company's public statements were false

and materially misleading throughout the class period. When the market learned

the truth about Ventyx, investors suffered damages.

The Schall Law Firm represents investors around the world and specializes in

securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some

jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm

Brian Schall, Esq.,

www.schallfirm.com

Office: 310-301-3335

info@schallfirm.com

SOURCE: The Schall Law Firm

View the original press release

(https://www.accesswire.com/856629/final-deadline-imminent-the-schall-law-firm-encourages-investors-in-ventyx-biosciences-inc-with-losses-of-100000-to-contact-the-firm)

on accesswire.com

Copyright 2024 ACCESSWIRE. All Rights Reserved.